About Univercells
Univercells is a company based in Charleroi (Belgium) founded in 2013 by Jose Castillo.. Univercells has raised $150.64 million across 10 funding rounds from investors including KKR, Korea Investment Holdings and Gates Foundation. The company has 87 employees as of December 31, 2023. Univercells has completed 1 acquisition, including SynHelix. Univercells operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Charleroi, Belgium
- Employees 87 as on 31 Dec, 2023
- Founders Jose Castillo
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Univercells Sa
-
Annual Revenue
$22.55 M (USD)39as on Dec 31, 2022
-
Net Profit
$-7.12 M (USD)19as on Dec 31, 2022
-
EBITDA
$-7.12 M (USD)19as on Dec 31, 2022
-
Total Equity Funding
$150.64 M (USD)
in 10 rounds
-
Latest Funding Round
$43.33 M (USD), Series D
Oct 19, 2022
-
Investors
KKR
& 19 more
-
Employee Count
87
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Univercells
Univercells has successfully raised a total of $150.64M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $43.33 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Series D — $43.3M
-
First Round
First Round
(23 Oct 2015)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2022 | Amount | Series D - Univercells | Valuation | SFPI , SRIW | |
| Dec, 2020 | Amount | Series C - Univercells | Valuation | Adjuvant Capital , Sai Food Products | |
| Feb, 2020 | Amount | Series C - Univercells | Valuation | KKR |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Univercells
Univercells has secured backing from 20 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include KKR, Korea Investment Holdings and Gates Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is deployed for global health technology innovations.
|
Founded Year | Domain | Location | |
|
AdBio Partners is engaged in early-stage life sciences investments.
|
Founded Year | Domain | Location | |
|
Venture capital is provided by TCD Capital to scale-ups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Univercells
Univercells has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include SynHelix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Enzyme-based DNA synthesis technology is developed for large-scale production.
|
2019 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Univercells
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Univercells Comparisons
Competitors of Univercells
Univercells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Univercells
Frequently Asked Questions about Univercells
When was Univercells founded?
Univercells was founded in 2013 and raised its 1st funding round 2 years after it was founded.
Where is Univercells located?
Univercells is headquartered in Charleroi, Belgium. It is registered at Charleroi, Walloon Region, Belgium.
Is Univercells a funded company?
Univercells is a funded company, having raised a total of $150.64M across 10 funding rounds to date.
How many employees does Univercells have?
As of Dec 31, 2023, the latest employee count at Univercells is 87.
What is the annual revenue of Univercells?
Annual revenue of Univercells is $22.55M as on Dec 31, 2022.
What does Univercells do?
Univercells was established in 2013 in Charleroi, Belgium, to focus on biomanufacturing technologies for the biopharma sector. Instrument systems have been developed for producing antibodies, proteins, and vaccines. Proprietary platforms, including the Scale-X bioreactor and Nevoline, are utilized for upstream processing of viral products. These technologies support the delivery of viral vaccines and gene therapies through scalable bioprocessing solutions.
Who are the top competitors of Univercells?
Univercells's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
How many acquisitions has Univercells made?
Univercells has made 1 acquisition, including SynHelix.
Who are Univercells's investors?
Univercells has 20 investors. Key investors include KKR, Korea Investment Holdings, Gates Foundation, European Investment Bank, and Farallon Capital Management.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.